Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

viatris limited - loperamide hydrochloride 2mg - capsule - 2 mg - active: loperamide hydrochloride 2mg excipient: erythrosine gelatin   indigo carmine   iron oxide black lactose monohydrate magnesium stearate maize starch opacode quinoline yellow titanium dioxide   - diamide is indicated for the symptomatic control of acute and chronic diarrhoea. in patients with an ileostomy it can be used to reduce the number and volume of stools and to harden their consistency.

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

inova pharmaceuticals (new zealand) limited - bromhexine hydrochloride 0.8 mg/ml; pholcodine 1 mg/ml;  ;  ;   - oral solution - 0.8mg/1mg per ml - active: bromhexine hydrochloride 0.8 mg/ml pholcodine 1 mg/ml       excipient: citric acid glycerol grenadine flavour 053040 hyetellose methyl hydroxybenzoate patent blue v propyl hydroxybenzoate purified water quinoline yellow saccharin sodium sorbitol

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - cyproterone acetate 2mg;  ; ethinylestradiol 0.035mg;   - film coated tablet - active: cyproterone acetate 2mg   ethinylestradiol 0.035mg   excipient: croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose opadry buff oy-3690 opadry white y-1r-7000b opaglos white 6000 povidone purified water quinoline yellow sucrose lactose monohydrate magnesium stearate microcrystalline cellulose - estelle-35 and estelle-35 ed are indicated for the treatment of androgen dependent diseases in women, such as acne (where oral antibiotics or local treatment alone has not been successful), especially pronounced forms and those which are accompanied by seborrhoea or by inflammation or formation of nodes (acne papulopustulosa, acne nodulocystica), androgenic alopecia, mild forms of hirsutism. estelle-35 and estelle-35 ed are also indicated for oral contraception in women requiring treatment for these androgen-dependent diseases; it is not recommended in women solely for contraception. estelle-35 and estelle-35 ed are also indicated for treating the symptoms of polycystic ovary syndrome.

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - hydrochlorothiazide 12.5mg;  ;  ; losartan potassium 50mg;   - film coated tablet - 50mg/12.5mg - active: hydrochlorothiazide 12.5mg     losartan potassium 50mg   excipient: carnauba wax hyprolose hypromellose lactose monohydrate magnesium stearate microcrystalline cellulose quinoline yellow starch titanium dioxide - hypertension hyzaar is indicated for the treatment of hypertension, for patients in whom combination therapy is appropriate. reduction in the risk of cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy hyzaar is a combination of losartan (cozaar) and hydrochlorothiazide. in patients with hypertension and left ventricular hypertrophy, losartan, often in combination with hydrochlorothiazide, reduces the risk of cardiovascular morbidity and mortality as measured by the combined incidence of cardiovascular death, stroke, and myocardial infarction in hypertensive patients with left ventricular hypertrophy.

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

viatris limited - carbidopa monohydrate 26.9mg equivalent to carbidopa 25 mg (contains approx. 7% moisture); levodopa 100mg - tablet - 100mg/25mg - active: carbidopa monohydrate 26.9mg equivalent to carbidopa 25 mg (contains approx. 7% moisture) levodopa 100mg excipient: magnesium stearate microcrystalline cellulose povidone purified talc quinoline yellow sodium starch glycolate starch - kinson is indicated for the treatment of parkinson's disease and syndrome. it is useful in relieving many of the symptoms of parkinsonism, particularly rigidity and bradykinesia. kinson frequently is helpful in the management of tremor, dysphagia, sialorrhea, and postural instability associated with parkinson's disease and syndrome. when therapeutic response to levodopa alone is irregular, and signs and symptoms of parkinson's disease are not evenly controlled throughout the day, substitution of kinson usually is effective in reducing fluctuations in response. by reducing certain adverse reactions produced by levodopa alone, kinson permits more patients to obtain adequate relief of the symptoms of parkinson's disease. kinson is also indicated for patients with parkinsonism who are taking vitamin preparations that contain pyridoxine hydrochloride (vitamin b6).

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

viatris limited - clarithromycin 250mg;  ; clarithromycin 250mg - film coated tablet - 250 mg - active: clarithromycin 250mg   excipient: croscarmellose sodium hydrated silica hyprolose hypromellose magnesium stearate microcrystalline cellulose povidone propylene glycol purified talc quinoline yellow   sorbic acid sorbitan oleate starch stearic acid titanium dioxide vanillin active: clarithromycin 250mg excipient: colloidal silicon dioxide croscarmellose sodium ethanol   hyprolose hypromellose magnesium stearate microcrystalline cellulose povidone propylene glycol purified talc purified water quinoline yellow   sorbic acid sorbitan oleate starch stearic acid titanium dioxide vanillin - klacid tablets are indicated for treatment of infections caused by susceptible organisms. such infections include: · respiratory tract infections including bronchitis, pneumonia, tonsillitis, sinusitis and pharyngitis. · skin and soft tissue infections such as folliculitis, cellulitis and erysipelas. · disseminated or localized mycobacterial infections due to mycobacterium avium or mycobacterium intracellulare. localized infections due to mycobacterium chelonae, mycobacterium fortuitum, or mycobacterium kansasii. · prevention of disseminated mycobacterium avium complex infection in hiv-infected patients with cd4 lymphocyte counts less than or equal to 100/mm3. · clarithromycin in the presence of acid suppression is indicated for the treatment of duodenal ulcer and in reducing the rate of ulcer recurrence.

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

viatris limited - clarithromycin 500mg;  ; clarithromycin 500mg - film coated tablet - 500 mg - active: clarithromycin 500mg   excipient: croscarmellose sodium hydrated silica hyprolose hypromellose magnesium stearate microcrystalline cellulose povidone propylene glycol purified talc quinoline yellow sorbic acid sorbitan oleate stearic acid titanium dioxide vanillin active: clarithromycin 500mg excipient: colloidal silicon dioxide croscarmellose sodium ethanol   hyprolose hypromellose magnesium stearate microcrystalline cellulose povidone propylene glycol purified talc purified water quinoline yellow sorbic acid sorbitan oleate stearic acid titanium dioxide vanillin - klacid tablets are indicated for treatment of infections caused by susceptible organisms. such infections include: · respiratory tract infections including bronchitis, pneumonia, tonsillitis, sinusitis and pharyngitis. · skin and soft tissue infections such as folliculitis, cellulitis and erysipelas. · disseminated or localized mycobacterial infections due to mycobacterium avium or mycobacterium intracellulare. localized infections due to mycobacterium chelonae, mycobacterium fortuitum, or mycobacterium kansasii. · prevention of disseminated mycobacterium avium complex infection in hiv-infected patients with cd4 lymphocyte counts less than or equal to 100/mm3. · clarithromycin in the presence of acid suppression is indicated for the treatment of duodenal ulcer and in reducing the rate of ulcer recurrence.

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - furosemide 10 mg/ml; furosemide 10 mg/ml - oral solution - 10 mg/ml - active: furosemide 10 mg/ml excipient: butylated hydroxyanisole butylated hydroxytoluene ethanol glycerol methyl hydroxybenzoate orange flavour 987431 polysorbate 80 potassium sorbate quinoline yellow sodium hydroxide sorbitol water active: furosemide 10 mg/ml excipient: ethanol glycerol methyl hydroxybenzoate orange flavour propyl hydroxybenzoate purified water quinoline yellow sodium hydroxide sorbitol sunset yellow fcf - oedema lasix is indicated in adults, infants and children for the treatment of oedema associated with congestive heart failure, cirrhosis of the liver and renal disease including the nephrotic syndrome. lasix is particularly useful when an agent with greater diuretic potential than that of those commonly employed is desired. parenteral therapy should be reserved for patients unable to take oral medication or for patients in emergency clinical situations. lasix injection is also indicated as adjunctive therapy in acute pulmonary oedema and cerebral oedema where intense and rapid onset of diuresis is desired. if gastrointestinal absorption is impaired or oral medication is not practical for any reason, lasix is indicated by the intravenous route. parenteral use should be replaced with oral lasix as soon as practical.

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - lithium carbonate 250mg - capsule - 250 mg - active: lithium carbonate 250mg excipient: brilliant blue fcf gelatin lactose monohydrate magnesium stearate maize starch quinoline yellow sunset yellow fcf - · treatment of mania and hypomania. · treatment of some patients with recurrent bipolar depression, for which treatment with other antidepressants have been unsuccessful. · prophylactic treatment of recurrent affective disorders.

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

boucher & muir (new zealand) limited t/a bnm group - hydrochlorothiazide 12.5mg; losartan potassium 50mg - film coated tablet - 50mg/12.5mg - active: hydrochlorothiazide 12.5mg losartan potassium 50mg excipient: hypromellose lactose monohydrate macrogol 4000 magnesium stearate microcrystalline cellulose pregelatinised maize starch purified talc quinoline yellow titanium dioxide - losartan hctad is indicated for the treatment of hypertension, for patients in whom combination therapy is appropriate.